Search

everythinglearnresearchcommunity

for

Search:↓

Bone Morphogenetic Proteins (BMPs) are important for hair growth, and their decrease due to hormones could lead to hair loss, but adding more BMPs could promote hair growth.

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Ephrin-A3 helps increase and speed up hair growth in baby mice.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Low-frequency electromagnetic fields can boost molecules related to hair growth in human skin cells.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

Maintaining healthy mitochondria may help treat hair loss.

Nutritional interventions can help restore balance in male health by targeting oxidative stress and hormonal issues.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Using minoxidil with tocopherol acetate in ethosomes improves hair regrowth in hair loss treatment.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.